Join
Live feed
·
NEWSReleasevia Quantisnow
CollPlant Biotechnologies Ltd logo

CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants

ByQuantisnow·Wall Street's wire, on your screen.
CLGN· CollPlant Biotechnologies Ltd
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLGN (CollPlant Biotechnologies Ltd) and more on Quantisnow.